ipsa5 Feb 2013 08:44
The SP level was around 3p before any news on the Iris deal so the additional $3.1M IPSA have received would equate to approx 1.8p on the price.
Given that & the macro market recovery thats been happening subsequently, the current price doesnt reflect any premium associated with a successful conclusion of the sale, hence nothing built in atm.
That, along with the limited number of free shares etc should bode very well for that major re-rating of the price & sustained upward movement looking towards increasing plant capacity & sector demand.
Very much under the radar atm but one with a genuinely strong platform fora multiple appreciation of its currrent sp.
dyor of course & gla